Preferred Label : triazoles;

MeSH definition : Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3.;

MeSH synonym : Triazole;

MeSH annotation : includes triazolines, triazolidines;

Wikipedia link : https://en.wikipedia.org/wiki/Triazole;

Is substance : O;

Details


Main resources

You can consult :

Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3.

https://www.has-sante.fr/jcms/p_3242562/jyseleca
2021
false
false
false
France
insurance, health, reimbursement
treatment outcome
filgotinib
filgotinib
filgotinib
administration, oral
female
arthritis, rheumatoid
Janus Kinase Inhibitors
Janus Kinase Inhibitors
evaluation of the transparency committee
GLPG0634
GLPG0634
pyridines
triazoles
pyridines
triazoles

---
https://www.ema.europa.eu/en/medicines/human/EPAR/nexpovio
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
selinexor
selinexor
drug approval
europe
selinexor
antineoplastic agents
antineoplastic agents
multiple myeloma
antineoplastic combined chemotherapy protocols
dexamethasone
Bortezomib/Dexamethasone/Selinexor Regimen
adult
aged
Refractory Multiple Myeloma
administration, oral
Exportin 1 Protein
drug monitoring
Female of Childbearing Potential
pregnancy
breast feeding
drug evaluation, preclinical
Product containing precisely selinexor 20 milligram/1 each conventional release oral tablet (clinical drug)
Bortezomib
hydrazines
triazoles
hydrazines
triazoles
receptors, cytoplasmic and nuclear
karyopherins

---
https://www.has-sante.fr/jcms/p_3147912/fr/posaconazole-mylan
2020
false
false
false
France
posaconazole
drugs, generic
evaluation of the transparency committee
posaconazole
triazoles

---
https://www.ema.europa.eu/en/medicines/human/EPAR/jyseleca
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
filgotinib
filgotinib
filgotinib
adult
arthritis, rheumatoid
administration, oral
drug therapy, combination
methotrexate
Janus Kinase Inhibitors
Janus Kinase Inhibitors
product surveillance, postmarketing
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
GLPG0634
GLPG0634
pyridines
triazoles
pyridines
triazoles

---
https://www.has-sante.fr/jcms/p_3181649/fr/posaconazole-fresenius-kabi
2020
false
false
false
France
administration, oral
posaconazole
insurance, health, reimbursement
treatment outcome
evaluation of the transparency committee
posaconazole
triazoles
triazoles

---
https://www.has-sante.fr/jcms/p_3151447/fr/posaconazole-zentiva
2020
false
false
false
France
drugs, generic
posaconazole
evaluation of the transparency committee
posaconazole
triazoles

---
https://www.has-sante.fr/jcms/p_3146433/fr/posaconazole-eg
2020
false
false
false
France
drugs, generic
evaluation of the transparency committee
posaconazole
triazoles

---
https://www.has-sante.fr/jcms/p_3117999/fr/posaconazole-ahcl
2019
false
false
false
France
administration, oral
posaconazole
antifungal agents
treatment outcome
insurance, health, reimbursement
drugs, generic
aspergillosis
invasive aspergillosis
fusariosis
chromoblastomycosis
mycetoma
coccidioidomycosis
Oropharyngeal Candidiasis
candidiasis, oral
Invasive Fungal Infections
evaluation of the transparency committee
posaconazole
triazoles

---
https://www.has-sante.fr/jcms/p_3119786/fr/inovelon
2019
false
false
false
France
rufinamide
administration, oral
child
Lennox Gastaut Syndrome
anticonvulsants
infant
evaluation of the transparency committee
inovelon
rufinamide
triazoles

---
https://www.has-sante.fr/jcms/p_3117950/fr/posaconazole-ohre-pharma
2019
false
false
false
France
administration, oral
treatment outcome
insurance, health, reimbursement
posaconazole
antifungal agents
drugs, generic
invasive aspergillosis
aspergillosis
fusariosis
chromoblastomycosis
mycetoma
candidiasis, oral
adult
Oropharyngeal Candidiasis
Invasive Fungal Infections
evaluation of the transparency committee
posaconazole
triazoles

---
https://www.ema.europa.eu/en/medicines/human/EPAR/posaconazole-ahcl
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drugs, generic
posaconazole
triazoles

---
https://www.ema.europa.eu/en/medicines/human/EPAR/posaconazole-accord
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
posaconazole
drugs, generic
triazoles

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00431
2019
false
false
false
Canada
French
drug information
drug approval
canada
treatment outcome
suvorexant
suvorexant
suvorexant
administration, oral
sleep initiation and maintenance disorders
Orexin Receptor Antagonists
Orexin Receptor Antagonists
azepines
triazoles
azepines
triazoles

---
https://www.has-sante.fr/portail/jcms/c_2965623/fr/delstrigo
https://www.has-sante.fr/portail/jcms/c_2965623/fr/delstrigo-doravirine-lamivudine-tenofovir-disoproxil-association-d-antiretroviraux
2019
false
true
false
false
France
French
treatment outcome
Tenofovir Disoproxil
Tenofovir
lamivudine
DORAVIRINE
drug combinations
lamivudine, tenofovir disoproxil and doravirine
adult
hiv infections
anti-hiv agents
administration, oral
reverse transcriptase inhibitors
evaluation of the transparency committee
insurance, health, reimbursement
guidelines for drug use
HIV-1
doravirine
pyridones
triazoles

---
https://www.has-sante.fr/portail/jcms/c_2965620/fr/pifeltro
https://www.has-sante.fr/portail/jcms/c_2965620/fr/pifeltro-doravirine-antiretroviral
2019
false
true
false
false
France
French
treatment outcome
DORAVIRINE
doravirine
reverse transcriptase inhibitors
anti-hiv agents
adult
hiv infections
administration, oral
aged
evaluation of the transparency committee
insurance, health, reimbursement
guidelines for drug use
HIV-1
anti-retroviral agents
Non-nucleoside Reverse Transcriptase Inhibitor
pyridones
triazoles
pyridones
triazoles
pyridones
triazoles

---
https://www.ema.europa.eu/en/medicines/human/EPAR/pifeltro
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
DORAVIRINE
DORAVIRINE
doravirine
reverse transcriptase inhibitors
reverse transcriptase inhibitors
anti-hiv agents
anti-hiv agents
adult
hiv infections
administration, oral
product surveillance, postmarketing
drug therapy, combination
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
pyridones
triazoles
pyridones
triazoles

---
https://www.ema.europa.eu/en/medicines/human/EPAR/delstrigo
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Tenofovir Disoproxil
Tenofovir
lamivudine
DORAVIRINE
Tenofovir Disoproxil
DORAVIRINE
lamivudine
drug combinations
drug approval
europe
Tenofovir
lamivudine, tenofovir disoproxil and doravirine
adult
hiv infections
anti-hiv agents
anti-hiv agents
administration, oral
reverse transcriptase inhibitors
reverse transcriptase inhibitors
product surveillance, postmarketing
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
pyridones
triazoles
pyridones
triazoles

---
https://www.has-sante.fr/jcms/p_3117944/fr/posaconazole-accord
2019
false
false
false
France
antifungal agents
administration, oral
posaconazole
treatment outcome
insurance, health, reimbursement
drugs, generic
aspergillosis
fusariosis
chromoblastomycosis
mycetoma
coccidioidomycosis
adult
Invasive Fungal Infections
invasive aspergillosis
evaluation of the transparency committee
posaconazole
triazoles

---
https://www.has-sante.fr/portail/jcms/c_2869665/fr/celsentri
2018
false
true
false
false
France
French
evaluation of the transparency committee
adolescent
child
adult
treatment outcome
HIV-1
hiv infections
hiv infections
CCR5 Receptor Antagonists
CCR5 Receptor Antagonists
Genotype drug resistance test
maraviroc
administration, oral
drug therapy, combination
selzentry
cyclohexanes
triazoles
cyclohexanes
triazoles
cyclohexanes
triazoles
Maraviroc
Maraviroc
Maraviroc

---
https://www.has-sante.fr/portail/jcms/c_2854458/fr/zurampic
2018
false
false
false
France
French
treatment outcome
lesinurad
lesinurad
uricosuric agents
drug therapy, combination
administration, oral
gout
adult
aged
Product containing lesinurad in oral dose form (medicinal product form)
evaluation of the transparency committee
thioglycolates
triazoles

---
https://ansm.sante.fr/actualites/lansm-rappelle-la-necessite-de-disposer-dune-nouvelle-prescription-pour-obtenir-exjade-90-mg-ou-360-mg-comprimes-pellicules-seule-forme-disponible-a-compter-du-26-juillet-2018-point-dinformation
2018
false
false
false
false
France
French
drug prescriptions
administration, oral
guidelines for drug use
patient education handout
iron overload
iron chelating agents
iron chelating agents
beta-Thalassemia
blood transfusion
medication errors
deferasirox
triazoles
benzoates
triazoles
benzoates
Deferasirox
Deferasirox

---
https://www.has-sante.fr/portail/jcms/c_2848372/fr/celsentri
https://www.has-sante.fr/portail/jcms/c_2848372/fr/celsentri-maraviroc-antiretroviral-antagoniste-du-recepteur-ccr5
2018
false
false
false
false
France
French
evaluation of the transparency committee
adolescent
child
adult
treatment outcome
guidelines for drug use
HIV-1
hiv infections
hiv infections
CCR5 Receptor Antagonists
CCR5 Receptor Antagonists
Genotype drug resistance test
maraviroc
selzentry
cyclohexanes
triazoles
cyclohexanes
triazoles
cyclohexanes
triazoles
Maraviroc
Maraviroc

---
https://www.has-sante.fr/portail/jcms/c_2842737/fr/exjade
2018
false
false
false
false
France
French
evaluation of the transparency committee
exjade
triazoles
benzoates
Deferasirox

---
https://www.anses.fr/fr/system/files/PHYTO2018SA0289.pdf
2018
false
true
false
false
France
epoxiconazole
fungicides, industrial
legislation, drug
europe
technical report
endocrine disruptors
epoxy compounds
triazoles

---
https://www.ema.europa.eu/medicines/human/EPAR/Duzallo
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
lesinurad
allopurinol
drug approval
europe
drug combinations
treatment outcome
product surveillance, postmarketing
allopurinol, combinations
adult
gout
administration, oral
uricosuric agents
uricosuric agents
gout suppressants
gout suppressants
SLC22A12 protein, human
xanthine oxidase
enzyme inhibitors
enzyme inhibitors
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
allopurinol
lesinurad
thioglycolates
triazoles
thioglycolates
triazoles
organic anion transporters
organic cation transport proteins

---
http://www.cochrane.org/fr/CD010031/quel-est-le-meilleur-medicament-pour-traiter-une-infection-fongique-de-longle-de-pied
2017
false
false
false
France
United Kingdom
French
french abstract
onychomycosis
administration, oral
antifungal agents
treatment outcome
comparative effectiveness research
Onychomycosis of toenails (disorder)
foot dermatoses
Evidence-Based medicine
terbinafine
Product containing terbinafine in oral dose form (medicinal product form)
griseofulvin
griseofulvin
Product containing griseofulvin in oral dose form (medicinal product form)
Medicinal product containing azole and acting as antifungal agent (product)
triazoles
Triazole and tetrazole derivatives
recurrence
review of literature
naphthalenes
Terbinafine

---
http://www.inrs.fr/publications/bdd/fichetox/fiche.html?refINRS=FICHETOX_314
2017
false
false
false
France
French
toxicological data sheet
tebuconazole
triazoles

---
https://pharmacomedicale.org/medicaments/par-specialites/item/rufinamide
2017
false
true
false
France
rufinamide
rufinamide
anticonvulsants
anticonvulsants
Voltage-Gated sodium channel blockers
Lennox Gastaut Syndrome
drug information
rufinamide
triazoles
triazoles
triazoles

---
http://www.has-sante.fr/portail/jcms/c_2745132/fr/exjade
2017
false
false
false
France
French
evaluation of the transparency committee
administration, oral
insurance, health, reimbursement
treatment outcome
iron chelating agents
deferasirox
iron overload
chronic disease
child
adolescent
thalassemia syndrome, nos
thalassemia
adult
blood transfusion
benzoates
triazoles
Deferasirox

---
https://www.ema.europa.eu/medicines/human/EPAR/Zurampic
2016
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
lesinurad
lesinurad
lesinurad
uricosuric agents
uricosuric agents
pregnancy
breast feeding
drug interactions
drug therapy, combination
administration, oral
gout
product surveillance, postmarketing
adult
aged
drug evaluation, preclinical
Product containing lesinurad in oral dose form (medicinal product form)
thioglycolates
triazoles
thioglycolates
triazoles

---
http://www.has-sante.fr/portail/jcms/c_2633059/fr/noxafil
2016
false
false
false
France
French
evaluation of the transparency committee
antifungal agents
posaconazole
posaconazole
adult
aspergillosis
fusariosis
chromoblastomycosis
mycetoma
coccidioidomycosis
chemoprevention
mycoses
immunocompromised host
treatment outcome
invasive aspergillosis
invasive fungal infection
infusions, intravenous
triazoles

---
Product confusion alert - Posanol (posaconazole) – Oral dosage forms not interchangeable
https://www.hc-sc.gc.ca/dhp-mps/medeff/bulletin/hpiw-ivps_2016-11-fra.php#a2-2
2016
false
false
false
Canada
French
English
administration, oral
medication errors
posaconazole
posaconazole
pharmacovigilance note
canada
antifungal agents
tablets
suspensions
Delayed-Action preparations
biological availability
triazoles

---
http://www.has-sante.fr/portail/jcms/c_2621471/fr/cresemba
http://www.has-sante.fr/portail/jcms/c_2621471/fr/cresemba-isavuconazole-antifongique
2016
false
false
false
false
France
French
evaluation of the transparency committee
administration, oral
infusions, intravenous
isavuconazole
isavuconazole
isavuconazole
treatment outcome
antifungal agents
antifungal agents
aspergillosis
invasive aspergillosis
mucormycosis
adult
orphan drug production
guidelines for drug use
nitriles
pyridines
triazoles
nitriles
pyridines
triazoles

---
https://pharmacomedicale.org/medicaments/par-specialites/item/autres-antiretroviraux
2016
false
false
false
France
French
drug information
hiv fusion inhibitors
hiv infections
enfuvirtide
maraviroc
CCR5 Receptor Antagonists
Raltegravir Potassium
raltegravir
HIV integrase inhibitors
anti-retroviral agents
peptide fragments
HIV envelope protein gp41
cyclohexanes
triazoles
Enfuvirtide
Maraviroc

---
https://www.ema.europa.eu/medicines/human/EPAR/Cresemba
2015
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
orphan drug production
isavuconazole
isavuconazole
antifungal agents
antifungal agents
drug approval
europe
invasive aspergillosis
adult
aspergillosis
mucormycosis
infusions, intravenous
administration, oral
product surveillance, postmarketing
drug interactions
breast feeding
pregnancy
14-alpha demethylase inhibitors
14-alpha demethylase inhibitors
drug evaluation, preclinical
drug compounding
isavuconazole
nitriles
pyridines
triazoles
nitriles
pyridines
triazoles

---
http://www.has-sante.fr/portail/jcms/c_2038286/fr/inovelon
2015
true
France
French
administration, oral
anticonvulsants
epilepsy
triazoles
rufinamide
rufinamide
orphan drug production
rare diseases
triazoles
intellectual disability
spasms, infantile
epileptic encephalopathy, Lennox-Gastaut type
evaluation of the transparency committee
Lennox-Gastaut syndrome
intellectual disability
spasms, infantile

---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=69380042
2015
false
false
false
France
French
summary of product characteristics
package leaflet
evaluation of the transparency committee
posaconazole
triazoles

---
http://www.has-sante.fr/portail/jcms/c_2559130/fr/xelevia
2015
false
false
false
France
French
evaluation of the transparency committee
pyrazines
triazoles

---
http://www.has-sante.fr/portail/jcms/c_2561558/fr/celsentri
2015
false
false
false
France
French
evaluation of the transparency committee
cyclohexanes
triazoles
Maraviroc

---
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2014/39911a-fra.php
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2014/39915a-fra.php
2014
false
false
false
Canada
French
English
ointments
administration, intravaginal
anaphylaxis
antifungal agents
epidermal necrolysis, toxic
terconazole
terconazole
Product containing precisely terconazole 4 milligram/1 milliliter conventional release vaginal cream (clinical drug)
Product containing precisely terconazole 8 milligram/1 milliliter conventional release vaginal cream (clinical drug)
Product containing precisely terconazole 80 milligram/1 each conventional release vaginal pessary (clinical drug)
vaginal suppositories
pharmacovigilance note
Drug-induced anaphylaxis (disorder)
stevens-johnson syndrome
triazoles

---
https://www.jle.com/fr/revues/abc/e-docs/antifongiques_triazoles_interet_et_modalites_du_suivi_therapeutique_pharmacologique_et_perspectives_doptimisation_des_traitements_302259/article.phtml
10.1684/abc.2014.0968
2014
false
false
false
France
French
journal article
mycoses
immune tolerance
antifungal agents
triazoles
fluconazole
itraconazole
14-alpha demethylase inhibitors
posaconazole
Voriconazole
drug monitoring
antifungal agents
triazoles

---
http://www.inrs.fr/accueil/produits/bdd/doc/fichetox.html?refINRS=FT%20302
2014
false
false
false
France
French
toxicological data sheet
triazoles
triazoles
triazoles
nitriles
nitriles
nitriles
fungicides, industrial
occupational exposure
systhane
nitriles
triazoles

---
http://www.has-sante.fr/portail/jcms/c_1778227/fr/noxafil
2014
false
false
false
France
French
evaluation of the transparency committee
administration, oral
tablets, enteric-coated
antifungal agents
posaconazole
posaconazole
adult
aspergillosis
fusariosis
chromoblastomycosis
mycetoma
coccidioidomycosis
chemoprevention
mycoses
immunocompromised host
treatment outcome
invasive aspergillosis
invasive fungal infection
triazoles

---
http://www.meddispar.fr/Medicaments/INOVELON-40-B-1/(type)/letter/(value)/I/(cip)/3400922069128
2014
false
false
false
France
French
drug information
administration, oral
pharmaceutical solutions
drug prescriptions
legislation, drug
rufinamide
anticonvulsants
rufinamide
triazoles

---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=62205873
2014
false
false
false
France
French
summary of product characteristics
package leaflet
rufinamide
rufinamide
suspensions
suspension, nos
triazoles

---
https://www.anses.fr/fr/system/files/EAUX2013sa0083.pdf
2013
false
true
false
France
drinking water
france
2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide
biphenyl compounds
epoxiconazole
epoxy compounds
drinking water
water pollution, chemical
water pollution, chemical
water pollution, chemical
water pollution, chemical
evaluation studies
chlormequat
biphenyl compounds
niacinamide
epoxy compounds
triazoles

---
https://www.anses.fr/fr/content/avis-de-l%E2%80%99anses-relatif-%C3%A0-la-d%C3%A9termination-de-valeurs-sanitaires-maximales-pour-le-chlorure
2013
false
true
false
water pollutants
chlormequat chloride
2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide
epoxiconazole
guidelines
chlormequat
humans
drinking
biphenyl compounds
niacinamide
epoxy compounds
triazoles

---
https://www.ema.europa.eu/medicines/human/EPAR/Noxafil
2012
false
United Kingdom
English
French
syndication feed
Contraindications, Procedure
triazoles
antifungal agents
mycoses
triazoles
antifungal agents
triazoles
antifungal agents
triazoles
antifungal agents
antifungal agents
administration, oral
aspergillosis
fusarium
chromoblastomycosis
mycetoma
coccidioidomycosis
candidiasis, oral
immunocompromised host
mycoses
adult
drug interactions
pregnancy
breast feeding
triazoles
triazoles
antifungal agents
drug evaluation, preclinical
triazoles
antifungal agents
drug labeling
drug approval
posaconazole
posaconazole
triazoles
drug evaluation
package leaflet
summary of product characteristics
Contraindications, Drug

---
https://www.ema.europa.eu/medicines/human/EPAR/Celsentri
2012
false
United Kingdom
English
French
CCR5 Receptor Antagonists
CCR5 Receptor Antagonists
syndication feed
hiv infections
hiv fusion inhibitors
cyclohexanes
tablets
administration, oral
adult
HIV-1
acquired immunodeficiency syndrome
drug therapy, combination
cyclohexanes
cyclohexanes
triazoles
triazoles
hiv fusion inhibitors
hiv fusion inhibitors
treatment outcome
cyclohexanes
triazoles
hiv fusion inhibitors
drug interactions
drug approval
drug labeling
pregnancy
triazoles
triazoles
cyclohexanes
hiv fusion inhibitors
drug resistance, viral
triazoles
cyclohexanes
hiv fusion inhibitors
drug evaluation, preclinical
breast feeding
maraviroc
summary of product characteristics
drug evaluation
package leaflet
Maraviroc
Maraviroc

---
https://www.anses.fr/fr/system/files/DPR2011sa0207.pdf
2011
France
French
scientific and technical information
chelating agents
edetic acid
lignosulfuric acid
lignin
3-methylpyrazole
dicyandiamido
guanidines
pyrazoles
1,2,4-triazole
triazoles
edetic acid
N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid

---
https://www.ema.europa.eu/medicines/human/EPAR/Posaconazole-SP
2009
United Kingdom
French
English
syndication feed
Contraindications, Procedure
triazoles
antifungal agents
mycoses
triazoles
antifungal agents
triazoles
antifungal agents
triazoles
antifungal agents
pharmaceutical solutions
administration, oral
adult
immunocompromised host
aspergillosis
fusarium
candidiasis, oral
chromoblastomycosis
coccidioidomycosis
drug labeling
drug approval
treatment outcome
drug evaluation
mycetoma
triazoles
triazoles
antifungal agents
antifungal agents
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
triazoles
antifungal agents
posaconazole
posaconazole
triazoles
drug evaluation
package leaflet
summary of product characteristics
Contraindications, Drug

---
http://www.has-sante.fr/portail/jcms/c_818998/inovelon-rufinamide-antiepileptique
http://www.has-sante.fr/portail/jcms/c_766830/inovelon-ct-6044
2009
France
French
anticonvulsants
epilepsy
triazoles
rufinamide
rufinamide
orphan drug production
rare diseases
triazoles
intellectual disability
spasms, infantile
epileptic encephalopathy, Lennox-Gastaut type
guidelines for drug use
evaluation of the transparency committee
Lennox-Gastaut syndrome

---
http://www.has-sante.fr/portail/jcms/c_865545/tests-de-determination-du-tropisme-du-vih-1-dans-le-cadre-du-traitement-avec-un-antagoniste-du-recepteur-a-chimiokines-ccr5
http://www.has-sante.fr/portail/jcms/c_870286/rapport-tests-de-tropisme
2009
true
France
French
CCR5 Receptor Antagonists
HIV-1
viral tropism
cyclohexanes
triazoles
hiv infections
anti-retroviral agents
hiv fusion inhibitors
phenotype
genotype
health technology assessment
treatment outcome
Maraviroc

---
http://www.meddispar.fr/medicaments/3769557
2008
France
French
benzoates
iron chelating agents
administration, oral
triazoles
tablets
continuity of patient care
drug monitoring
drug prescriptions
legislation, drug
adult
child
deferasirox
drug information
Deferasirox

---
http://www.meddispar.fr/medicaments/3769511
2008
France
French
benzoates
continuity of patient care
adult
triazoles
child
drug prescriptions
legislation, drug
administration, oral
tablets
drug monitoring
drug information
Deferasirox

---
https://www.cadth.ca/sites/default/files/cdr/complete/cdr_complete_Spriafil_January-30-2008_fr.pdf
2007
Canada
French
canada
insurance, health, reimbursement
antifungal agents
candidiasis
aspergillosis
candidiasis
aspergillosis
triazoles
posaconazole
posaconazole
triazoles
drug evaluation

---
https://www.cadth.ca/sites/default/files/pdf/E0036_Maraviroc_cetap_fr.pdf
https://www.cadth.ca/sites/default/files/pdf/E0036_Maraviroc_cetap_e.pdf
2007
false
Canada
French
English
CCR5 Receptor Antagonists
CCR5 Receptor Antagonists
CCR5 Receptor Antagonists
triazoles
hiv infections
HIV-1
hiv fusion inhibitors
cyclohexanes
drug resistance, multiple, viral
treatment outcome
adult
Evidence-Based medicine
cyclohexanes
cyclohexanes
triazoles
triazoles
hiv fusion inhibitors
hiv fusion inhibitors
canada
randomized controlled trials as topic
maraviroc
drug evaluation
Maraviroc
Maraviroc
Maraviroc

---
http://www.has-sante.fr/portail/jcms/c_574573/fr/noxafil
2007
false
true
false
France
French
English
evaluation of the transparency committee
administration, oral
antifungal agents
posaconazole
posaconazole
adult
fusariosis
chromoblastomycosis
mycetoma
coccidioidomycosis
chemoprevention
mycoses
immunocompromised host
treatment outcome
invasive aspergillosis
invasive fungal infection
pharmaceutical solutions
Oropharyngeal Candidiasis
candidiasis
aspergillosis
triazoles

---
https://reptox.cnesst.gouv.qc.ca/pages/fiche-complete.aspx?no_produit=1214527&nom=Myclobutanil
2005
Canada
French
nitriles
triazoles
systhane
nitriles
triazoles
toxicological data sheet

---
https://minerva-ebp.be/fr/article/580
2004
false
false
minerva-ebm.be
Belgium
French
tamoxifen
treatment outcome
nitriles
triazoles
antineoplastic combined chemotherapy protocols
chemotherapy, adjuvant
aged
survival rate
breast neoplasms
antineoplastic agents, hormonal
aromatase inhibitors
nitriles
triazoles
critical appraisal or critical reading
comparative study
Anastrozole

---
Nous contacter.
26/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.